close 73% de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor. Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 73% de inversores minoristas pierde dinero al operar CFDs con este proveedor. Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
BuscarBuscar
Change languageEspañol
Dashboard

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Inicio・Lista de Acciones・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Cerrado

SectorSanidad

32.33 -0.28

Compra Fuerte

Precios actualizados 12 dic 2025, 20:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

32.11

Máximo

32.86

Métricas clave

By Trading Economics

Ingresos

66M

-35M

Ventas

70M

71M

Margen de beneficios

-49.028

Empleados

143

EBITDA

66M

-34M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+25.24% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

888M

3B

Apertura anterior

32.61

Cierre anterior

32.33

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

187 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

12 / 13.14 Soporte y Resistencia

VIRIDIAN THERAPEUTICS INC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 dic 2025, 16:42 UTC

Adquisiciones, fusiones, absorciones

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

DJ

Leer

12 dic 2025, 23:49 UTC

Adquisiciones, fusiones, absorciones

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

DJ

Leer

12 dic 2025, 22:52 UTC

Charlas de Mercado

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

DJ

Leer

12 dic 2025, 22:32 UTC

Ganancias

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

DJ

Leer

12 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

DJ

Leer

12 dic 2025, 20:45 UTC

Ganancias

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

DJ

Leer

12 dic 2025, 20:41 UTC

Charlas de Mercado

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

DJ

Leer

12 dic 2025, 20:20 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

DJ

Leer

12 dic 2025, 19:23 UTC

Ganancias

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

DJ

Leer

12 dic 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

DJ

Leer

12 dic 2025, 18:33 UTC

Adquisiciones, fusiones, absorciones

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

DJ

Leer

12 dic 2025, 18:31 UTC

Charlas de Mercado

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

DJ

Leer

12 dic 2025, 17:49 UTC

Ganancias

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

DJ

Leer

12 dic 2025, 17:34 UTC

Adquisiciones, fusiones, absorciones

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

DJ

Leer

12 dic 2025, 17:33 UTC

Adquisiciones, fusiones, absorciones

Orange: Closing of the Transaction Is Expected in the First Half of 2026

DJ

Leer

12 dic 2025, 17:33 UTC

Adquisiciones, fusiones, absorciones

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

DJ

Leer

12 dic 2025, 17:32 UTC

Adquisiciones, fusiones, absorciones

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

DJ

Leer

12 dic 2025, 17:31 UTC

Adquisiciones, fusiones, absorciones

Orange to Buy the Stake for EU4.25B in Cash

DJ

Leer

12 dic 2025, 17:24 UTC

Charlas de Mercado

Argentina Predicts Record Wheat Crop -- Market Talk

DJ

Leer

12 dic 2025, 17:20 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

DJ

Leer

12 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

DJ

Leer

12 dic 2025, 17:18 UTC

Charlas de Mercado
Ganancias

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

DJ

Leer

12 dic 2025, 17:09 UTC

Charlas de Mercado

Broadcom Investors Were Primed to Sell Shares -- Market Talk

DJ

Leer

12 dic 2025, 17:09 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

DJ

Leer

12 dic 2025, 16:47 UTC

Charlas de Mercado

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

DJ

Leer

12 dic 2025, 16:39 UTC

Charlas de Mercado

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

DJ

Leer

12 dic 2025, 16:27 UTC

Adquisiciones, fusiones, absorciones

FTC Sues to Block Henkel's $725M Deal for Liquid Nails From PE Firm -- 2nd Update

DJ

Leer

12 dic 2025, 16:15 UTC

Ganancias

At Costco, Lots of Pie but No Special Dividend. Why the Street Didn't Like the Earnings. -- Barrons.com

DJ

Leer

12 dic 2025, 15:35 UTC

Ganancias

These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

DJ

Leer

12 dic 2025, 14:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

DJ

Leer

Comparación entre iguales

Cambio de precio

VIRIDIAN THERAPEUTICS INC previsión

Precio Objetivo

By TipRanks

25.24% repunte

Estimación a 12 Meses

Media 40.79 USD  25.24%

Máximo 61 USD

Mínimo 14.302 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

15

Comprar

0

Mantener

0

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

12 / 13.14Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Bearish Evidence

All events are bearish.

Largo Plazo

Strong Bearish Evidence

All events are bearish.

Sentimiento

By Acuity

187 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Otras acciones del sector

LLY

Eli Lilly and Co.

1,027.44

↑ +2.13%

JNJ

Johnson and Johnson

211.44

↑ +0.72%

ABBV

AbbVie Inc

223.45

↓-0.16%

UNH

UnitedHealth Group Inc

341.39

↑ +1.44%

AZN

AstraZeneca PLC ADR

89.79

↓-0.45%
help-icon Live chat